Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.

Flexi4 contains…

Zoetis has announced the launch of Contacera (meloxicam) 15mg/ml oral suspension, a non-steriodal anti-inflammatory preparation for horses.

According to the company, meloxicam has been shown to hold advantages over Phenylbutazone for the alleviation of…

Zoetis has announced that Trocoxil, the once-monthly treatment for canine osteoarthritis, is back in stock following a supply shortage.

The company says it has been working hard to ensure improved supply on a number of brands including Apoquel, Palladia…

Zoetis has launched two, monthly treatments for osteoarthritis pain: Librela for dogs and Solensia for cats.

Zoetis says Librela (bedinvetmab) and Solensia (frunevetmab) work differently from NSAIDs, the current standard of care, by specifically targeting…

Zoetis has presented the results of two studies looking at the impact of Librela (bedinvetmab) and Solensia (frunevetmab) on the quality of life (QoL) of dogs and cats with osteoarthritis (OA).

For the studies, the owners of 68 dogs treated with Librela and…